First genetic study in Spain for Tarlov's cyst disease

Since last October we have been collaborating with the Tarlov Cysts Association in the first genetic study carried out in Spain for the identification of genetic variants associated with this pathology. Tarlov's cysts are arachnoid dilatations of the spinal cord occupied by cerebrospinal fluid that can occur at any level of the spinal cord... Read more

Application of massive sequencing in ophthalmology.

In the latest issue of IM Médico magazine dedicated to the specialty of Ophthalmology, we have published an article entitled "Application of massive sequencing to the diagnosis of ophthalmologic diseases" in which our colleagues Leyre Larzabal and Carlos Martínez discuss the usefulness of this technology and the improvement it has brought in the diagnosis of ophthalmologic diseases.

Dreamgenics and CEU San Pablo University sign an educational cooperation framework agreement

Dreamgenics and CEU San Pablo University sign a framework agreement for educational cooperation for the joint implementation of training, consulting and research activities. The CEU San Pablo University is the largest and most traditional private educational institution in Spain, founded in 1933 as a University College and, since 1993, as a private University, with a total of more than 1,000 students, ... Read more

ASEMPA Information Day

ASEMPA-Informative-Day

Last Wednesday we held an informative conference in collaboration with ASEMPA, Association of Muscular Diseases of the Principality of Asturias, in which our head of Clinical Genetics, Dr. Leyre Larzabal, spoke about neuromuscular diseases and the role of genetics in their diagnosis. We share with you the complete talk and we are at your disposal ... Read more

Dreamgenics signs a collaboration agreement with Objetivo Diagnóstico

Dreamgenics and Objetivo Diagnóstico Agreement

Objetivo Diagnóstico and Dreamgenics have signed a framework agreement of institutional collaboration to promote the genetic diagnosis of rare diseases, as well as to develop research projects and training activities related to them. The majority of RDDs are chronic and degenerative diseases, which means that patients suffering from them face chronic pain, difficulties ... Read More

Rare diseases: more refined diagnostics, more specific treatments

We participated in the IMMeeting organized by IMMédico to talk about rare diseases, their diagnosis and treatment,

Yesterday, February 23, we participated in the IMMeeting organized by IMMédico magazine to talk about rare diseases, their diagnosis and treatment, together with Beatriz Perales, member of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) and Ramón García, hematologist and head of the molecular biology laboratory of the University Hospital of Barcelona (Hospital Universitario de ... Read more

APADA Seminar: Hearing Loss and Genetics

Hearing loss is the loss of hearing, to a lesser or greater degree, which may be caused by environmental or genetic causes. It is estimated that about 80% of newly diagnosed cases of hearing loss have a hereditary basis and affect, according to WHO, 360 million people worldwide. Last Thursday, we conducted a ... Read more

Dreamgenics signs a collaboration agreement with Ana Carolina Díez Mahou Foundation

Agreement-ana-carolina-mahou-ana-carolina-foundation

Ana Carolina Díez Mahou Foundation and Dreamgenics have signed a framework agreement of institutional collaboration to promote the genetic diagnosis of neuromuscular diseases, as well as the realization of research projects and training activities related to them. From Dreamgenics we offer our genetic diagnosis services to patients and their families to contribute in the best way possible to the development of the ... Read more